✨ Your Portfolio is fetched and updated from zerodha.
Micro Textiles

Trident Texofab Ltd.

TTFL

Market Cap
₹272 Cr.
P/E
143.52

Trident Texofab Ltd.

  • Trident Texofab
  • MK Exim India
  • Integra Essentia
FAQs on Trident Texofab Ltd. Shareprice

Trident Texofab has given better returns compared to its competitors.
Trident Texofab has grown at ~75.08% over the last 2yrs while peers have grown at a median rate of 1.47%

Yes, Trident Texofab is expensive.
Latest PE of Trident Texofab is 143, while 3 year average PE is 102.
Also latest EV/EBITDA of Trident Texofab is 67.51 while 3yr average is 22.12.

View FAQ's On Business
Growth Table
  • Trident Texofab Ltd.
  • MK Exim India
  • Integra Essentia
Balance Sheet
  • Trident Texofab Ltd.
  • MK Exim India
  • Integra Essentia
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Trident Texofab Ltd.
  • MK Exim India
  • Integra Essentia
Cash Flow
  • Trident Texofab Ltd.
  • MK Exim India
  • Integra Essentia
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Trident Texofab Ltd.
  • MK Exim India
  • Integra Essentia
Quarterly Results
  • Trident Texofab Ltd.
  • MK Exim India
  • Integra Essentia
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Trident Texofab Ltd. Financials

Balance sheet of Trident Texofab is strong.
But short term working capital might become an issue for this company.

Yes, The debt of Trident Texofab is increasing.
Latest debt of Trident Texofab is ₹37.75 Crs as of Sep-24.
This is greater than Mar-24 when it was ₹36.76 Crs.

The profit is oscillating.
The profit of Trident Texofab is ₹1.9 Crs for TTM, ₹1.08 Crs for Mar 2024 and ₹2.22 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Trident Texofab latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Inventory, Accounts Receivable

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech